kanamycin a has been researched along with Hodgkin Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curtis, JE; Feld, R; Hasselback, R; Messner, HA; Tuffnell, PG | 1 |
| Dall, G; Jenkin, DJ | 1 |
2 other study(ies) available for kanamycin a and Hodgkin Disease
| Article | Year |
|---|---|
Empiric therapy for infections in granulocytopenic cancer patients: continuous infusion of amikacin plus cephalothin.
Topics: Acute Disease; Amikacin; Bacterial Infections; Cephalothin; Drug Therapy, Combination; Gram-Negative Aerobic Bacteria; Gram-Negative Anaerobic Bacteria; Hodgkin Disease; Humans; Infusions, Parenteral; Kanamycin; Leukemia | 1979 |
Lesions of bone in disseminated infection due to the mycobacterium avium-intracellulare group. Report of a case.
Topics: Adolescent; Bone Diseases; Bone Neoplasms; Child; Diagnosis, Differential; Ethambutol; Hodgkin Disease; Humans; Isoniazid; Kanamycin; Male; Mycobacterium; Mycobacterium avium; Mycobacterium Infections; Radiography; Rifampin; Time Factors | 1975 |